Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic

International Journal of Tuberculosis and Lung Disease

Volumn 8, Issue 5, 2004, Pages 574-578

  Kassa Kelembho, Eric ^a   Bobossi Serengbe, G ^a   Takeng, E C ^a,b   Nambea Koisse, T B ^a   Yapou, F ^a   Talarmin, A ^a  

^a INSTITUT PASTEUR DE BANGUI   (Central African Republic)

^b République centrafricaine   (Central African Republic)

Author keywords

Central African Republic; Children; Drug resistance; Surveillance; Tuberculosis

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; CENTRAL AFRICAN REPUBLIC; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; DRUG SURVEILLANCE PROGRAM; EPIDEMIOLOGICAL DATA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; TUBERCULOSIS;

EID: 2442457856     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Snider D E Jr, Castro K G. The global threat of drug-resistant tuberculoisis. N Engl J Med 1998; 338: 1689-1690.
2. Pablos-Mendez A, Raviglione M C, Laszlo A, et al. Global surveillance of antituberculosis-drug resistance 1994-1997. World Health Organization/International Union Against Tuberculosis and Lung Disease. Working group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 1998; 338: 1641-1649.
3. Tuberculosis Programme World Health Organization, Geneva, and International Union Against Tuberculosis and Lung Disease, Paris. Guidelines for surveillance of drug resistance in tuberculosis. WHO/TB/94.178. Geneva, Switzerland: WHO, 1994.
4. Van Rie A, Warren R, Richardson M, et al. Classification of drug-resistance tuberculosis in an epidemic area. Lancet 2000; 356: 22-25.
5. Steiner P, Rao M, Mitchell M, Steiner M, Primary drug-resistant tuberculosis in children. Emergence of primary drug-resistant strains of M. tuberculosis to rifampicin. Am Rev Respir Dis 1986; 134: 446-448.
6. Dilber E, Gocmen A, Kiper N, Ozcelik U. Drug-resistant tuberculosis in Turkish children. Turk J Pediatr 2000; 42: 145-147.
7. Schaaf H S, Gie R P, Beyers N, Sirgel F A, de Klerk P J, Donald P R. Primary drug-resistant tuberculosis in children. Int J Tuberc Lung Dis 2000; 4: 1149-1155.
8. Dye C, Scheele S, Dolin P, Pathania V, Raviglione M C. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999; 282: 677-686.
9. Garin B, Glaziou P, Kassa-Kelembho E, Yassibanda S, Mbelesso P, Morvan J. High mortality rates among patients with tuberculosis in Bangui, Central African Republic. Lancet 1997; 350: 1298.
10. Garin B, Di Costanzo B, Kassa-Kelembho E, et al. Drug-resistant Mycobacterium tuberculosis strains in tuberculosis inpatients in Bangui, Central African Republic. AIDS 1995; 9: 213-214.
11. World Health Organization/International Union Against Tuberculosis and Lung Disease. Anti-Tuberculosis Drug Resistance in the World. Report No 2. The WHO/IUATLD Global Project on Anti-Tuberculosis Drug Resistance Surveillance 1997-2000. WHO/TB/2000.278. Geneva, Switzerland: WHO, 2000.
12. Espinal M A, Laszlo A, Simonsen L, et al. Global trends in resistance to antituberculosis drugs. World Health Organization/International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance. N Engl J Med 2001; 344: 1294-1303.
13. Menard D, Mandeng M J, Bem Tothy M, Kassa-Kelembho E, Gresenguet G, Talarmin A. Immunohematological references ranges for adults from Central African Republic. Clin Diagn Lab Immunol 2003; 10: 443-445.
14. David H, Lew-Frébault V, Thorel M F. Méthodes de laboratoire de mycobactériologie clinique. Paris, France: Presse Institut Pasteur, 1989.
15. Canetti G, Rist N, Grosset J. Mesure de la sensibilité du bacille tuberculeux aux drogues anti-bacillaires par la méthode des proportions. Rev Tuberc Pneumol 1963; 27: 217-272.
16. Harries A D, Maher D. Diagnosis of tuberculosis in children. TB/VIH: a clinical manual. WHO/TB/96.200. Geneva, Switzerland: World Health Organization, 1996: 61-68.
17. American Thoracic Society/Centers for Disease Control and Prevention. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149: 1359-1374.
18. Sandman L, Schluger N W, Davidow A L, Bonk S. Risk factors for rifampin-monoresistance tuberculosis. A case-control study. Am J Crit Care Med 1999; 159: 468-472.
19. Bloch A B, Cauthen G M, Onorato I M, et al. Nationwide survey of drug-resistant tuberculosis in the United States. JAMA 1994; 271: 665-671.